Status:
RECRUITING
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Anal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Anal cancer is a rare disease, but the incidence is rising. About 200 patients will get this type of cancer yearly in Sweden. Curative treatment includes chemotherapy and radiotherapy. The prognosis i...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Anal squamous carcinoma diagnosed within the last 2 months
Exclusion
- No informed consent
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2035
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04792892
Start Date
August 1 2021
End Date
April 1 2035
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden, SE 416 85